TrialOral oncology2014

Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer.

Nikhil G Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.